International Stem Cell Corp (ISCO) — 10-Q Filings
All 10-Q filings from International Stem Cell Corp. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
ISCO Narrows Losses, Sales Up Amid Persistent Going Concern Doubts
— Nov 13, 2025 Risk: high
International Stem Cell Corporation (ISCO) reported a net income of $57 thousand for the three months ended September 30, 2025, a significant improvement from a -
ISCO's Q2 Net Income Up, But Going Concern Looms Amid Widening H1 Loss
— Aug 14, 2025 Risk: high
International Stem Cell Corporation (ISCO) reported a net income of $129,000 for the three months ended June 30, 2025, an increase from $119,000 in the same per -
ISCO Files Q1 2025 10-Q: Focus on Biotech & Skincare
— May 14, 2025 Risk: medium
International Stem Cell Corp. (ISCO) filed its 10-Q for the quarter ending March 31, 2025. The company, formerly known as BTHC III INC., is involved in the phar -
International Stem Cell Corp. Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
International Stem Cell Corp. (ISCO) filed its Q3 2024 10-Q report on November 13, 2024, detailing its financial performance for the period ending September 30, -
International Stem Cell Corp Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
International Stem Cell Corp filed its 10-Q for the period ending June 30, 2024. The company reported on its financial condition and results of operations, incl -
International Stem Cell Corp Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: medium
International Stem Cell CORP (ISCO) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Filing is a 10-Q for International Stem Cell Corp (ISCO) for t
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX